Summary of opinion: Welireg, 12/11/2026 Positive
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
Summary of opinion: Welireg, 12/11/2026 Positive
Summary of opinion: Dovato, 12/11/2026 Positive
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
Summary of opinion: Dovato, 12/11/2026 Positive
Summary of opinion: Tivicay, 12/11/2026 Positive
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
Summary of opinion: Tivicay, 12/11/2026 Positive
Summary of opinion: Steglatro, 12/11/2026 Positive
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
Summary of opinion: Steglatro, 12/11/2026 Positive
Summary of opinion: Talzenna, 12/11/2026 Positive
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
Summary of opinion: Talzenna, 12/11/2026 Positive
Summary of opinion: Enflonsia, 12/11/2026 Positive
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
Summary of opinion: Enflonsia, 12/11/2026 Positive
Summary of opinion: Isturisa, 12/11/2026 Positive
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
Summary of opinion: Isturisa, 12/11/2026 Positive
EMA recommends extending Gazyvaro’s use to systemic lupus erythematosus
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
EMA recommends extending Gazyvaro’s use to systemic lupus erythematosus
Summary of opinion: Cosentyx, 12/11/2026 Positive
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
Summary of opinion: Cosentyx, 12/11/2026 Positive
Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Refused
Submitted by Anonymous (not verified) on 13 November 2026 - 11:00
Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Refused